Porcilis Ery+Parvo+Lepto suspension for injection for pigs
Porcilis Ery+Parvo+Lepto suspension for injection for pigs
Authorised
- Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated
- Porcine parvovirus, strain 014, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated
- Leptospira kirschneri, serogroup Grippotyphosa, serovar Dadas, strain GR-01-005, Inactivated
- Leptospira interrogans, serogroup Pomona, serovar Pomona, strain Po-01-000, Inactivated
- Leptospira santarosai, Serogroup Tarassovi, serovar Gatuni, strain S1148/02, Inactivated
- Leptospira interrogans, serogroup Australis, serovar Bratislava, strain As-05-073, Inactivated
Product identification
Medicine name:
Porcilis Ery+Parvo+Lepto suspension for injection for pigs
Porcilis Ery+Parvo+Lepto ενέσιμο εναιώρημα για χοίρους
Active substance:
- Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated
- Porcine parvovirus, strain 014, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated
- Leptospira kirschneri, serogroup Grippotyphosa, serovar Dadas, strain GR-01-005, Inactivated
- Leptospira interrogans, serogroup Pomona, serovar Pomona, strain Po-01-000, Inactivated
- Leptospira santarosai, Serogroup Tarassovi, serovar Gatuni, strain S1148/02, Inactivated
- Leptospira interrogans, serogroup Australis, serovar Bratislava, strain As-05-073, Inactivated
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated1.00Protective Dose2.00millilitre(s)
-
Porcine parvovirus, strain 014, Inactivated130.00enzyme-linked immunosorbent assay unit2.00millilitre(s)
-
Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated2816.00enzyme-linked immunosorbent assay unit2.00millilitre(s)
-
Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated210.00enzyme-linked immunosorbent assay unit2.00millilitre(s)
-
Leptospira kirschneri, serogroup Grippotyphosa, serovar Dadas, strain GR-01-005, Inactivated648.00enzyme-linked immunosorbent assay unit2.00millilitre(s)
-
Leptospira interrogans, serogroup Pomona, serovar Pomona, strain Po-01-000, Inactivated166.00enzyme-linked immunosorbent assay unit2.00millilitre(s)
-
Leptospira santarosai, Serogroup Tarassovi, serovar Gatuni, strain S1148/02, Inactivated276.00enzyme-linked immunosorbent assay unit2.00millilitre(s)
-
Leptospira interrogans, serogroup Australis, serovar Bratislava, strain As-05-073, Inactivated1310.00enzyme-linked immunosorbent assay unit2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Pig
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AL07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Cyprus
Package description:
- (ID6) 250 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 250 millilitre(s)
- (ID5) 100 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 100 millilitre(s)
- (ID4) 500 millilitre(s): Box (Cardboard) with 10 Bottle (PolyEthylene TerePhthalate) each with 50 millilitre(s)
- (ID3) 50 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 50 millilitre(s)
- (ID2) 200 millilitre(s): Box (Cardboard) with 10 Bottle (PolyEthylene TerePhthalate) each with 20 millilitre(s)
- (ID1) 20 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 20 millilitre(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
- CY00597V
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0268/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
France
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 15/03/2024
Summary of Product Characteristics
English (PDF)
Download Published on: 28/01/2022
How useful was this page?: